Investor’s Toolkit: Key Ratios for Assessing Axogen Inc. (AXGN)’s Performance

For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In other words, the price has increased by $0.00 from its previous closing price. On the day, 0.58 million shares were traded. AXGN stock price reached its highest trading level at $9.0 during the session, while it also had its lowest trading level at $8.62.

Ratios:

For a better understanding of AXGN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.23 and its Current Ratio is at 3.43. In the meantime, Its Debt-to-Equity ratio is 0.74 whereas as Long-Term Debt/Eq ratio is at 0.72.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Raymond James on July 01, 2024, initiated with a Outperform rating and assigned the stock a target price of $13.

Canaccord Genuity Upgraded its Hold to Buy on May 09, 2022, whereas the target price for the stock was revised from $10 to $15.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 21 ’24 when Zaderej Karen L. sold 39,280 shares for $7.68 per share. The transaction valued at 301,670 led to the insider holds 1,124,565 shares of the business.

Scopelianos Angelo sold 6,881 shares of AXGN for $52,846 on Mar 21 ’24. The Chief R&D Officer now owns 52,999 shares after completing the transaction at $7.68 per share. On Mar 21 ’24, another insider, Donovan Michael Patrick, who serves as the VP Operations of the company, sold 6,033 shares for $7.68 each. As a result, the insider received 46,333 and left with 37,992 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AXGN now has a Market Capitalization of 383726368 and an Enterprise Value of 438164160. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.34 while its Price-to-Book (P/B) ratio in mrq is 4.12. Its current Enterprise Value per Revenue stands at 2.676 whereas that against EBITDA is -32.728.

Stock Price History:

Over the past 52 weeks, AXGN has reached a high of $10.83, while it has fallen to a 52-week low of $3.45. The 50-Day Moving Average of the stock is 15.17%, while the 200-Day Moving Average is calculated to be 19.49%.

Shares Statistics:

Over the past 3-months, AXGN traded about 329.48K shares per day on average, while over the past 10 days, AXGN traded about 250360 shares per day. A total of 43.12M shares are outstanding, with a floating share count of 41.29M. Insiders hold about 5.53% of the company’s shares, while institutions hold 80.21% stake in the company. Shares short for AXGN as of 1721001600 were 2438897 with a Short Ratio of 7.40, compared to 1718323200 on 1915105. Therefore, it implies a Short% of Shares Outstanding of 2438897 and a Short% of Float of 6.6300004999999995.

Most Popular